Package 55154-4332-0

{"route": ["ORAL"], "spl_id": "06a2e4b5-cd82-445b-a707-eb21bb4d38f1", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0055154433204"], "unii": ["X4HES1O11F"], "rxcui": ["197311"], "spl_set_id": ["d8004652-86fe-4714-81d4-5e1dd2585bb4"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Cardinal Health 107, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "10 BLISTER PACK in 1 BAG (55154-4332-0)  / 1 TABLET in 1 BLISTER PACK", "package_ndc": "55154-4332-0", "marketing_start_date": "19990305"}], "brand_name": "Acyclovir", "product_id": "55154-4332_06a2e4b5-cd82-445b-a707-eb21bb4d38f1", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "55154-4332", "generic_name": "Acyclovir", "labeler_name": "Cardinal Health 107, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "400 mg/1"}], "application_number": "ANDA075382", "marketing_category": "ANDA", "marketing_start_date": "19990305", "listing_expiration_date": "20261231"}